The Relevance of a Significant Correlation Between ET-1 and Clinical Markers Such as Microalbuminuria and Fundus Oculi Changes in Early Detection of Diabetic Nephropathy in Type 2 Diabetes

Benereta Hoxha; Ilir Arapi; koneelsa

Authors

Benereta Hoxha
Ilir Arapi
koneelsa

Keywords:

biomarkers, endothelin-1, microalbuminuria, fundus oculi, diabetes, diabetic nephropathy

Abstract

Prolonged hyperglycemia and insulinre-sistance in type II diabetes are the main factors contributing to the damage of the vascular endothelium (endothelial dysfunction) leading to micro and macroangiopathy which result in significant amounts of damage towards many internal organs such as cardiovascular diseases, diabetic retinopathy (DR) and nefropathy (DN). Those pathologies frequently result life threatening for the patient. The employment of high-sensitivity biomarkers for the early detection endothelial dysfunction in general and more specifically for the renal endothelial dysfunction seems to represent a major step ahead towards an improvement in the management algorithms of diabetes and its severe complications. Purpose The aim of our study is to discover the correlations of endothelin-1 (ET1) with known clinical markers of endothelial dysfunction such as microalbuminuria (MA) and fundus oculi (FO) findings in order to help an early detection of renal damage and consequently preventing or slowing progress of diabetic nephropathy (DN). Materials and methods: This is a prospective study where some eighty type 2 diabetes patients were recruited and were dichotomized in 2 groups. In the first group were included forty patients with normoalbuminuria (urinary albumin 0-30 mg/24 hours) while in the second were included the remaining forty patients with microalbuminuria (urinary albumin 30-300 mg/24 hours). Plasma ET-1 levels and 24 hour urinary excretion of albumin were measured. Diabetic retinopathy assessment was made according to the International Clinical Diabetic Retinopathy Disease Severity Scale which includes 5 severity scales. The first scale without retinopathy, the second of light retinopathy non proliferative, the third of moderate non proliferative and the fourth severe retinopathy non proliferative and the fifth one of proliferative retinopathy. Results: We found a statistically significant correlation between ET-1 and MA (p

Downloads

How to Cite

The Relevance of a Significant Correlation Between ET-1 and Clinical Markers Such as Microalbuminuria and Fundus Oculi Changes in Early Detection of Diabetic Nephropathy in Type 2 Diabetes. (2014). Global Journal of Medical Research, 14(18), 1-5. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Download Citation

References

J. Am (1999) Ritz E, Rychlik I, Locatelli F, Halimi S: End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. 34(5), 795-808. https://doi.org/10.1016/s0272-6386(99)70035-1

P. Bahman, Tabaei, Abdul MPH, Al-Kassab, MD, Liza PHD, Ilag, Catherine MD, Zawacki, RN, William BSN, Herman, MD, MPH (2001) Does Microalbuminuria Predict Diabetic Nephropathy? 10. 24(9), 1560-1566. https://doi.org/10.2337/diacare.24.9.1560

Cda Stehouwer, J. Lambert, Ajm Donker, Vwm van Hinsbergh (1997) Endothelial dysfunction and pathogenesis of diabetic angiopathy.

Cda Stehouwer, J. Yudkin, P. Fioretto, R. Nosadini (1998) benign. 13, 2751-2754.

(2012) Diabetes Complications.

Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. 54, 1615-1625.

Sarah Yuan, Robert Rigor (2010) Sarah Y.

Regulation of Endothelial Barrier Function.

Konstantin Birukov (2009) Small GTPases in mechanosensitive regulation of endothelial barrier. 77(1), 46-52. https://doi.org/10.1016/j.mvr.2008.09.006

Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S (2009) Endothelial dysfunction as a target for prevention of cardiovascular disease. 32, 314-21.

M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, T. Masaki (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. 332(6163), 411-415.

a (1994) Contribution of endogenous generation of endothelin-1 to basal vascular tone b Haynes WG, Webb DJ Lancet. 344(8926), 852-854.

H. Ito, Y. Hirata, S. Adachi, M. Tanaka, M. Tsujino, A. Koike, A. Nogami, F. Murumo, M. Hiroe (1993) Endothelin- 1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes J Clin Invest. 92(1), 398-403. https://doi.org/10.1172/jci116579

World Health Organization (1985) Diabetes Mellitus: Report of a WHO Study Group.

(2002) American academy of ophthalmology.

C. Stehouwer (2004) Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease. 19, 778-81.

B. Becker, D. Chappell, D. Bruegger, T. Annecke, M. Jacob (2010) Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential.

Maria Potenza, Sara Gagliardi, Carmela Nacci, Maria Carratu, Monica Montagnani (2009) Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets Curr Med Chem. 16(1), 94-112. https://doi.org/10.2174/092986709787002853

X. Xu, S. Belmadani, Y. Park, Z. Tang, A. Feldman, W. Chilian, C. Zhang (2007) TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/ reperfusion injury. Gao X. 27(6), 1269-1275.

RG, A. Madden, J. Oliver, T. Lewis (2001) Effects of ET(A)- and ET(B)-receptor antagonists on regional kidney blood flow, and responses to intravenous endothelin-1, in anaesthetized rabbits. 19, 1789-1799.

Gerchmanlucas ZanattaFernando, Burttet Gustavo, Maria Nabinger, Jacques, H. SilvaLuís, Canani (2008) Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus Claudete M. 299-304.

Bg1 Seligman, A. Biolo, C. Polanczyk, J. Gross, N. Clausell (2000) Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia. 23(9), 1395-1400.

M. Simonson, W. Herman (1993) Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1: cross-talk between G protein-coupled receptors and pp60c- src J Biol Chem. 268(13), 9347-9357. https://doi.org/10.1016/s0021-9258(18)98357-2

Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH (2003) Vascular endothelial growth factor and diabetic retinopathy: pathophys-iological mechanisms and treatment perspectives. 19, 442-55.

Lucas R, Magez S, De R, Fransen L, Scheerlinck JP, Rampelberg M Lucas R, Magez S, De Leys R, Fransen L, Scheerlinck JP, Rampelberg M.

Caldwell RB, Zhang W, Romero MJ, Caldwell RW (2010) Vascular dysfunction in retinopathy-an emerging role for arginase. 81, 303-9.